Show simple item record

 
dc.contributorDepartament de Salut
dc.contributor.authorPlans-Rubió, Pedro
dc.date.accessioned2024-01-25T12:34:12Z
dc.date.available2024-01-25T12:34:12Z
dc.date.issued2021-03-13
dc.identifier.citationPlans-Rubió P. Vaccination Coverage for Routine Vaccines and Herd Immunity Levels against Measles and Pertussis in the World in 2019. Vaccines. 2021 Mar 13;9(3):256.
dc.identifier.urihttps://hdl.handle.net/11351/10904
dc.descriptionVaccination coverage; Anti-measles herd immunity; Anti-pertussis herd immunity
dc.description.abstractIn 2012, the World Health Organization (WHO) established the Global Vaccine Action Plan with the objective to promote essential vaccinations in all countries and achieve at least 90% vaccination coverage for all routine vaccines by 2020. The study assessed the mean percentages of vaccination coverage in 2019 for 13 routine vaccines, vaccination coverage variation from 2015 to 2019, and herd immunity levels against measles and pertussis in 2019 in countries and regions of WHO. In 2019, the mean percentages of vaccination coverage were lower than 90% for 10 (78.9%) routine vaccines. The mean percentages of vaccination coverage also decreased from 2015 to 2019 for six (46.2%) routine vaccines. The prevalence of individuals with vaccine-induced measles immunity in the target measles vaccination population was 88.1%, and the prevalence of individuals with vaccine-induced pertussis immunity in the target pertussis vaccination population was 81.1%. Herd immunity against measles viruses with Ro = 18 was established in 63 (32.5%) countries but not established in any region. Herd immunity against pertussis agents was not established in any country and in any region of WHO. National immunization programs must be improved to achieve ≥90% vaccination coverage in all countries and regions. Likewise, it is necessary to achieve ≥95% vaccination coverage with two doses of measles vaccines and three doses of pertussis vaccines in all countries and regions.
dc.language.isoeng
dc.publisherMDPI
dc.relation.ispartofseriesVaccines;9(3)
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceScientia
dc.subjectXarampió - Vacunació
dc.subjectTos ferina - Vacunació
dc.subjectImmunització
dc.subject.meshMeasles
dc.subject.meshWhooping Cough
dc.subject.meshImmunity, Herd
dc.subject.meshVaccination Coverage
dc.titleVaccination Coverage for Routine Vaccines and Herd Immunity Levels against Measles and Pertussis in the World in 2019
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.3390/vaccines9030256
dc.subject.decssarampión
dc.subject.decstos ferina
dc.subject.decsinmunidad de grupos
dc.subject.decscobertura de vacunación
dc.relation.publishversionhttps://doi.org/10.3390/vaccines9030256
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.authoraffiliationAgència de Salut Pública de Catalunya, Departament de Salut, Generalitat de Catalunya, Barcelona, Spain. Ciber of Epidemiology and Public Health (CIBERESP), Madrid, Spain
dc.identifier.pmid33805681
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record